对急性损伤肝综合征的血管收缩疗法:随机研究的元分析
Ashwani K Singal1,2, Geralyn Palmer1, Lauren Melick1
1Department of Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, South Dakota.
Gastro hep advances
|August 12, 2024
概括
特里普林和诺拉皮内弗林对肝综合征 (HRS) 的逆转有效,表现优于米多丁和八丁. 然而,没有任何治疗可以改善无肝移植生存率,反应取决于基线和肝功能.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 1型肝综合征 (HRS) 涉及肝硬化患者的功能快速下降.
- 在1型HRS中血管收缩剂的有效性数据显示不一致的结果.
研究的目的:
- 为了比较1型HRS的药理疗法的疗效.
- 评估包括HRS逆转,无肝移植生存率和严重不良事件在内的结果.
主要方法:
- 随机对照试验的系统审查,比较HRS治疗方法.
- 主要结局:HRS的逆转 (血清肌素<1.5mg/dL).
- 二级结局:无肝移植 (LT) 的生存率和严重不良事件 (SAE).
主要成果:
- 特里普林素与安慰剂相比,增加了HRS逆转几率的3.3倍,但没有改善无LT生存率和增加SAE风险.
- 与terlipressin相比,上腺素在HRS逆转,无LT生存率或SAE方面没有显著差异.
- 对于HRS逆转,terlipressin或norepinephrine优于midodrine/octreotide (midodrine/octreotide的几率降低了91%).
- 没有反应的人有更高的MELD得分和基线血清肌素水平.
结论:
- 特里普林和诺阿基尼林对HRS逆转有效,并且彼此相似.
- 对于HRS逆转,米多德林/奥克特雷奥提德组合疗法效果较差.
- 没有任何评估的治疗方法可以改善无LT存活率.
- 治疗反应与较低的基线MELD和肌素有关.
- 需要进行进一步的研究,以确定特定HRS治疗的最佳候选人.
相关概念视频
01:25Antihypertensive Drugs: Direct Renin Inhibitors
517
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
517
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
01:22Heart Failure Drugs: Diuretics
353
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
353
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
569
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
569
01:27Dialysis
281
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
281
01:16Antihypertensive Drugs: Action of Diuretics
642
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
642